Cambridge Associates LLC Amicus Therapeutics, Inc. Transaction History

Cambridge Associates LLC

  • $2.67 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022
SELL
$9.82 - $12.44 $288,197 - $365,089
-29,348 Closed
0 $0
Q3 2021

Dec 20, 2022
BUY
$8.74 - $11.84 $256,501 - $347,480
29,348 New
29,348 $280,000
Q3 2021

May 10, 2022
BUY
$8.74 - $11.84 $256,501 - $347,480
29,348 New
29,348 $280,000

Others Institutions Holding FOLD

# of Institutions
311
Shares Held
314M
Call Options Held
516K
Put Options Held
833K
View Full List

About AMICUS THERAPEUTICS, INC.

FOLD Quotes by TradingView
  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.53B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Cambridge Associates LLC Portfolio

Follow Cambridge Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Associates LLC , based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Associates LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email